Neogen Chemicals Reports Strong Q4 Results Amid Battery Material Expansion

Neogen Chemicals announced a significant jump in fourth-quarter profits, alongside a substantial investment from its promoters to bolster its expansion into battery materials.

Q4 and Full-Year Financial Highlights

For the fourth quarter of FY26, Neogen Chemicals reported consolidated revenue of ₹247 crore, marking a 22% year-on-year increase. Full-year consolidated revenue for FY26 reached ₹862 crore, up 11% from the previous year. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) for Q4 FY26 grew 21% year-on-year to ₹44 crore, with margins holding steady at 17.8% despite input cost pressures. However, full-year FY26 EBITDA saw a modest 1% increase to ₹137 crore. The company's consolidated Profit After Tax (PAT) for the full year FY26 was ₹29 crore, a 17% decrease from the prior year.

Strategic Pivot to Battery Materials

The company's promoters have demonstrated strong confidence by injecting ₹161 crore through a preferential allotment. This capital infusion is earmarked to accelerate Neogen's strategic expansion into high-growth sectors, particularly battery materials, aligning with India's 'Atmanirbhar Bharat' vision and the booming electric vehicle (EV) market.

Building Battery Chemical Capacity

Neogen Chemicals is making substantial investments in expanding its capacity, including key projects like the Pakhajan greenfield site, which will focus on lithium-ion battery materials. The company plans to commence commercial manufacturing of critical electrolyte components in the first half of FY27. This strategic direction leverages its expertise in specialized chemicals such as electrolyte salts and solvents. The recent acquisition of the Buli Chemicals India Private Limited facility further enhances its downstream integration capabilities.

Investor Impact and Future Outlook

This promoter commitment reassures shareholders about the company's future strategy and its potential in the burgeoning battery materials sector. The capital backing from promoters de-risks future expansion plans. Neogen is positioning itself to capture a significant share in India's growing battery chemicals market. The company also recommended a final dividend of ₹1 per equity share for FY26, pending shareholder approval.

Peer Landscape

While peers like Aarti Industries focus on benzene derivatives and SRF Ltd on fluorochemicals, Neogen's dedicated expansion into battery chemicals for EVs sets it apart. Jubilant Ingrevia is also a strong specialty chemical player. Neogen's focused investment strategy in this emerging market offers a unique growth trajectory.

Potential Risks

Forward-looking statements made by the company are subject to various risks and uncertainties. These can include potential government actions, local economic or political developments, and technological changes, all of which could impact actual business outcomes.

Looking Ahead

Investors will be watching the commissioning of the Dahej replacement plant by June 2026 and its subsequent ramp-up. Progress on customer qualification and final site audits for battery material products will be key. Furthermore, the commencement of commercial manufacturing at the Pakhajan Greenfield Project, starting with electrolytes in H1 FY27, and the integration and performance of the Buli Chemicals facility are important milestones. The company aims to achieve standalone revenue guidance of INR 875–950 crore for FY27.